Skip to content

REMEDIX

Active
Private limited companyfounded 20241 yr activeJ. de Troozlaan 71, 8370 Blankenberge, BelgiumKBO/BCE: BE 1016.845.753
Summary

REMEDIX has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €228,776 and a net result of €225,776. The computed 12-month bankruptcy probability is 1.4% (low).

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
1.4% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19,000 at 30 days only on tighter terms
Liquidity ample (current ratio 5.02; short-term debt: 13.6% and cash: 66.8% of total assets), and 13.6% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
86.4%
Return on assets
85.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-07-2026, 27 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
27 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 2 December 2024, REMEDIX was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€228,776
Total assets
€264,665
Net result
€225,776
Working capital
€144,109

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €264,665
Fixed assets €84,684
Current assets €179,981
Equity and liabilities €264,665
Equity €228,776
Debt €35,889
Debt finances 13.6% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€337,277
Cash flow
€237,138
Current ratio
5.02
Debt to equity
0.16
ROE
98.7%
ROA
85.3%
Interest coverage
42855.98
Debt ≤ 1 year
€35,873
Income taxes
€100,135

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 1.4% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 39 lines
Balance sheet Code2025
Assets
Total assets20/58€264,665
Fixed assets21/28€84,684
Tangible fixed assets22/27€84,684
Land and buildings22€66,563
Plant, machinery and equipment23€3,921
Furniture and vehicles24€14,200
Current assets29/58€179,981
Amounts receivable within one year40/41€1,242
Other amounts receivable41€1,242
Cash at bank and in hand54/58€176,884
Deferred charges and accrued income490/1€1,856
Equity and liabilities
Total equity and liabilities10/49€264,665
Equity10/15€228,776
Contributions10/11€3,000
Reserves13€225,776
Distributable reserves133€225,776
Amounts payable17/49€35,889
Amounts payable within one year42/48€35,873
Trade debts44€513
Suppliers440/4€513
Taxes, remuneration and social security45€35,135
Taxes450/3€35,135
Other amounts payable47/48€225
Accrued charges and deferred income492/3€16
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11,361
Other operating charges640/8€1,704
Gross operating margin9900€338,981
Operating profit (loss)9901€325,915
Financial income75/76B€4
Recurring financial income75€4
Financial charges65/66B€8
Recurring financial charges65€8
Profit (loss) for the period before taxes9903€325,911
Income taxes67/77€100,135
Profit (loss) for the period9904€225,776
Profit (loss) for the period to be appropriated9905€225,776
Appropriation of the result
Profit (loss) to be appropriated9906€225,776
Transfer to equity691/2€225,776
To other reserves6921€225,776

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11,361
Other operating charges640/8€1,704
Gross operating margin9900€338,981
Operating profit (loss)9901€325,915
Financial income75/76B€4
Recurring financial income75€4
Financial charges65/66B€8
Recurring financial charges65€8
Profit (loss) for the period before taxes9903€325,911
Income taxes67/77€100,135
Profit (loss) for the period9904€225,776
Profit (loss) for the period to be appropriated9905€225,776
Line2025
Assets
Total assets20/58€264,665
Fixed assets21/28€84,684
Tangible fixed assets22/27€84,684
Land and buildings22€66,563
Plant, machinery and equipment23€3,921
Furniture and vehicles24€14,200
Current assets29/58€179,981
Amounts receivable within one year40/41€1,242
Other amounts receivable41€1,242
Cash at bank and in hand54/58€176,884
Deferred charges and accrued income490/1€1,856
Equity and liabilities
Total equity and liabilities10/49€264,665
Equity10/15€228,776
Contributions10/11€3,000
Reserves13€225,776
Distributable reserves133€225,776
Amounts payable17/49€35,889
Amounts payable within one year42/48€35,873
Trade debts44€513
Suppliers440/4€513
Taxes, remuneration and social security45€35,135
Taxes450/3€35,135
Other amounts payable47/48€225
Accrued charges and deferred income492/3€16
Line2025
Profit (loss) for the period9904€225,776
+ Depreciation and write-downs630€11,361
Operating cash flow (approximation)€237,138

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
04-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 1 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Blankenberge · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
239 m²
Building footprint
184 m²
Parcel 31602A0842/00Z002, Flanders. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
REMEDIX
J. de Troozlaan 71, 8370 BlankenbergeGeneral medical practice
since 20242.367.061.009
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31602A0842/00Z002 Flanders 239 m² 1 · 184 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company details

Identification
Legal formPrivate limited company
Founded02-12-2024
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1016845753
Registered 13-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.